Inactive Instrument

News Peak Pharmaceuticals, Inc. Other OTC

Equities

CTCO

US70469W1062

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Retrieve Medical Announces Significant Results from Physician Burnout Study	05-02	AQ
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation	04-19	AQ
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation	04-19	CI
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software	03-22	AQ
Retrieve Medical Holdings, Inc. Announces Study Update Results Utilizing Retrieve Dx ? Software	03-22	CI
Retrieve Medical Holdings Inc announced that it expects to receive $3 million in funding	03-13	CI
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals	02-26	AQ
Retrieve Medical, Inc. Forges Partnership with Louisiana Health System Hospitals	02-26	CI
Retrieve Medical Holdings, Inc. Announces Patent for Enhancing Electronic Health Records	02-07	CI
Retrieve Medical. Inc. Announces Signed Letter of Intent with Louisiana Health System Hospitals, to Immediately Begin the Implementation Phase of Their Patented Software Solution, Retrieve DX	12-18	CI
Retrieve Medical Holdings, Inc. Announces Study Results Utilizing Retrieve Dx Software	24/10/23	CI
Peak Pharmaceuticals, Inc. announced that it has received $0.3185 million in funding	13/08/23	CI
Retrieve Medical. Inc. Announces New Contract with Healthcare Enterprise Technology Company	21/06/23	CI
Retrieve Medical, Inc. Announce Signed Contract with Regional Medical Center	31/05/23	CI
Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding	23/04/23	CI
Neil Reithinger Resigns as Sole Director of Peak Pharmaceuticals, Inc	28/03/23	CI
Neil Reithinger Resigns as Chief Financial Officer of Peak Pharmaceuticals, Inc	28/03/23	CI
Peak Pharmaceuticals, Inc. Announces CEO Changes	28/03/23	CI
Retrieve Medical, Inc. acquired Peak Pharmaceuticals, Inc. for $26.3 million in a reverse merger transaction.	27/03/23	CI
NOTE 2 - GOING CONCERN AND MANAGEMENT'S LIQUIDITY PLANS	09/02/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Peak Pharmaceuticals, Inc. Other OTC

Equities

CTCO

US70469W1062

Summary

Filters